- short tibia / IMPC
B6NCrl;B6N-Atm1Brd Icostm2a(EUCOMM)Wtsi/CipheOrl
Status | Available to order |
EMMA ID | EM:09743 |
International strain name | B6NCrl;B6N-Atm1Brd Icostm2a(EUCOMM)Wtsi/CipheOrl |
Alternative name | EPD0912_4_C07 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Icostm2a(EUCOMM)Wtsi |
Gene/Transgene symbol | Icos |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Centre d'ImmunoPhenomique - Ciphe |
Provider affiliation | Centre d'ImmunoPhenomique - Ciphe |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0912_4_C07. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NCrl |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Common variable immunodeficiency / Orphanet_1572
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal leukocyte cell number / MGI
- abnormal small intestine morphology / MGI
- abnormal spleen morphology / MGI
- abnormal immune system physiology / MGI
- decreased IgG level / MGI
- decreased IgA level / MGI
- abnormal T cell differentiation / MGI
- small lymph nodes / MGI
- abnormal spleen germinal center morphology / MGI
- abnormal Peyer's patch germinal center morphology / MGI
- abnormal T cell physiology / MGI
- abnormal B cell number / MGI
- abnormal B cell physiology / MGI
- abnormal immunoglobulin level / MGI
- decreased IgE level / MGI
- decreased anti-insulin autoantibody level / MGI
- abnormal cytokine secretion / MGI
- no phenotypic analysis / MGI
- decreased autoantibody level / MGI
- insulitis / MGI
- increased susceptibility to experimental autoimmune encephalomyelitis / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- abnormal class switch recombination / MGI
- abnormal B cell selection / MGI
- decreased T cell number / MGI
- abnormal response to infection / MGI
- decreased T cell proliferation / MGI
- endocrine/exocrine gland phenotype / MGI
- immune system phenotype / MGI
- abnormal CD4-positive, alpha-beta T cell physiology / MGI
- abnormal T-helper 2 physiology / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- abnormal memory B cell number / MGI
- increased plasma cell number / MGI
- decreased plasma cell number / MGI
- small Peyer's patches / MGI
- decreased germinal center B cell number / MGI
- decreased spleen germinal center number / MGI
- decreased spleen germinal center size / MGI
- decreased IgG1 level / MGI
- decreased IgG2a level / MGI
- decreased IgG2b level / MGI
- increased IgG3 level / MGI
- decreased interferon-gamma secretion / MGI
- abnormal interleukin secretion / MGI
- decreased circulating interferon-gamma level / MGI
- decreased circulating interleukin-4 level / MGI
- decreased interleukin-4 secretion / MGI
- decreased interleukin-5 secretion / MGI
- abnormal interferon level / MGI
- abnormal interleukin level / MGI
- decreased IgG2c level / MGI
- decreased interleukin-21 secretion / MGI
- decreased pancreatic islet number / MGI
- abnormal NK cell physiology / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).